SPARK: Supporting Physical Activity Through Reality-Augmented Knowledge in COPD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGroupe Hospitalier du Havre

About this trial

Chronic obstructive pulmonary disease (COPD) is associated with dyspnea, reduced physical activity, muscle deconditioning, and impaired quality of life. Pulmonary rehabilitation is an effective non-pharmacological intervention, but access remains limited and long-term adherence to physical exercise is often difficult to maintain. Augmented reality may provide an innovative approach to support exercise practice by offering real-time visual and auditory guidance while allowing patients to remain anchored in their real environment.

The SPARK study is a multicenter, interventional, non-randomized, proof-of-concept study designed to assess the acceptability of an augmented reality virtual coach for physical exercise in adults with COPD. Participants will attend a single experimental session including baseline questionnaires, presentation of the augmented reality headset, a short immersive exercise session guided by a virtual coach, and post-immersion assessments. Acceptability will be evaluated using the Technology Acceptance Model 3 questionnaire before and after immersion. User experience will also be explored through focus group discussions analyzed according to UXive dimensions.

The study aims to determine whether this technology is acceptable to patients with COPD and to identify factors that may facilitate or limit its future integration into pulmonary rehabilitation pathways.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years Diagnosis of chronic obstructive pulmonary disease (COPD) confirmed according to GOLD recommendations, defined by a post-bronchodilator FEV1/FVC ratio < 0.70 No exacerbation during the previous month, defined as hospitalization or major therapeutic modification related to worsening respiratory symptoms Written informed consent obtained before any study-related procedure Affiliation to a social security system

Disqualifiers

COPD exacerbation during the previous month Major motor disorders, disabling osteoarticular conditions, or significant functional dependence preventing safe participation in physical exercises Insufficient cognitive or language abilities to understand instructions, complete questionnaires, or participate in the semi-structured interview Photosensitive epilepsy Uncorrected or atypical visual and/or hearing impairment Patient under legal guardianship, curatorship, or incarcerated Pregnant or breastfeeding woman

Trial design

Design model

Single group

Treatments tested in this trial

  • Augmented Reality Virtual Coach

    Device

    Participants will use an augmented reality headset delivering a virtual coach-guided exercise session. The intervention consists of a single approximately 20-minute immersive session performed in a secured environment. The virtual coach provides standardized instructions and corrective feedback during strengthening exercises. The session includes calf raises, sit-to-stand exercises, and stretching. The intervention is designed to assess the acceptability and user experience of an augmented reality-based exercise support tool in adults with chronic obstructive pulmonary disease.

Treatment groups

42 Participants
are divided into 1 treatment group
Group A: Augmented Reality Virtual Coach SessionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Global Acceptability Score of the Augmented Reality Virtual Coach

Acceptability will be assessed using the global score of the adapted Technology Acceptance Model 3 questionnaire completed immediately after the augmented reality immersion session. Items are rated on a 7-point Likert scale, with higher scores indicating greater acceptability. The mean global score will be compared with the theoretical neutral value of 4.

Time frame
Immediately after the augmented reality immersion session, during the single study visit

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Groupe Hospitalier du Havre

Lead sponsor

GRHVN Université Rouen

Collaborator

HAVAE Université Limoges

Collaborator

ADIR Association

Collaborator